ICP incidence at nearly 3% worldwide, but varies by region: Study
Intrahepatic cholestasis of pregnancy was estimated to affect 2.9% of women globally, with highest numbers in Asia and lowest in Oceania.| Liver Disease News
Intrahepatic cholestasis of pregnancy was estimated to affect 2.9% of women globally, with highest numbers in Asia and lowest in Oceania.| Liver Disease News
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, including stroke, gene regulation, cancer, and rare...| Liver Disease News
Read about his other PH news from around the web.| Liver Disease News
Enrollment is complete in the Phase 2b VISTAS clinical trial, which is testing the experimental oral treatment volixibat in people with itching due to primary sclerosing cholangitis (PSC). Top-line results from VISTAS (NCT04663308), whose recruitment reached 182 participants, are expected between April and June of next year. “Completing enrollment in VISTAS is a major milestone […] The post Phase 2 trial of volixibat for PSC-related itching now fully enrolled appeared first on Liver Disea...| Liver Disease News – The Web's Daily Resource for Liver Disease News
Newly identified mutations in the LSR gene were the likely cause of progressive familial intrahepatic cholestasis (PFIC) in three unrelated children — two of whom showed a more complex clinical profile that included growth issues and neurological impairment. That’s according to a new case series that detailed the diagnosis of PFIC in the three youngsters, all […] The post Newly ID’d LSR gene mutations are likely cause of PFIC in 3 children appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
Since I learned I’d become a full-fledged metabolic dysfunction-associated steatohepatitis (MASH) patient, I’ve collected an assortment of friends with different medical issues. One of my good friends learned of her type 2 diabetes shortly before finding out she also had MASH. It was a double whammy after years of dealing with other health problems, and […] The post A smartwatch helps me monitor symptoms of fatty liver disease appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
As part of a merger deal, Roche will acquire 89bio and its treatment candidate pegozafermin — an injection therapy now being tested in two global clinical trials for metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease. Under the terms of the definitive merger agreement between the companies, Roche will buy 89bio for about […] The post Roche to acquire 89bio, will get pegozafermin for MASH in deal appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
Our family has been extremely busy lately. The beginning of the school year is always an exciting yet exhausting time as we settle back into our fall routine. While this season brings familiar changes, it often wipes out my boys in ways I don’t always anticipate. It has been particularly challenging for my youngest son, […] The post Adapting to a new routine is made harder by regular hospital visits appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
Bylvay (odevixibat), an oral medication used to treat cholestatic pruritus — severe itching that results from a buildup of bile acids used in digestion — is now approved in Canada for people with Alagille syndrome. The decision by Health Canada will make the Ipsen medication available to adults and children, ages 1 and older, with […] The post Bylvay now approved in Canada to treat adults, children with Alagille appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
The U.S. Food and Drug Administration (FDA) has given Lion TCR the green light to start Phase 1b/2 clinical trials testing LioCyx-M004, the clinical-stage biotechnology company’s experimental cell therapy for chronic hepatitis B. The FDA clearance to launch the trials follows the agency’s granting of both fast track and orphan drug designations to the treatment […] The post FDA OKs clinical trials to test cell therapy for chronic hepatitis B appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
Intercept Pharmaceuticals has voluntarily withdrawn Ocaliva (obeticholic acid), an oral therapy used to treat certain adults with primary biliary cholangitis (PBC), from the U.S. market following a request from the U.S. Food and Drug Administration (FDA). The FDA has also placed a clinical hold on all Intercept-sponsored Ocaliva clinical trials underway in the U.S., the […] The post PBC treatment Ocaliva leaves U.S. market amid safety concerns appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
I enjoy listening to the sounds of the city outside my bedroom window at night. Cars hum down the thoroughfare where I live, their headlights splashing brief bursts of light across my wall. All too often, though, ambulance or police sirens will shriek past, bound for nearby hospitals. I live on a nearly direct path […] The post When facing a hospital stay, pack a bag and hope for chocolate cake appeared first on Liver Disease News.| Liver Disease News – The Web's Daily Resource for Liver Disease News
Nesfatin-1 (NF-1), a hormone that may ease cellular stress, reduced injury to the placenta in a mouse model of ICP, a study found.| Liver Disease News
Columnist Jay Sandstrom didn't expect his son's routine surgery to involve complications. But with Alagille syndrome, anything is possible.| Liver Disease News
Health Canada has authorized a point-of-care test that may be used to quickly diagnose hepatitis C and monitor treatment response.| Liver Disease News
Mitochondrial problems may contribute to cholestasis-related liver damage and represent a potential therapeutic target, a study reports.| Liver Disease News
Rezdiffra has become the first approved therapy for some people with severe fatty liver disease in the European Union.| Liver Disease News
The FDA has conditionally approved Wegovy (semaglutide) to treat certain people with a serious form of fatty liver disease.| Liver Disease News
Hepatitis B treatment needs a global overhaul to meet the WHO’s goal of eliminating the virus as a public health threat by 2030, per a study.| Liver Disease News
Columnist Kathryn Hudson has been tempted to seek advice from "Dr. Google," but she knows it's a poor substitute for a medical professional.| Liver Disease News
Eating healthy foods is vital with liver disease, but inflation can make this challenging. Columnist Kathryn Hudson shares her budget tips.| Liver Disease News
Category archive page for Fatty liver disease.| Liver Disease News
Hepatitis treatment differs based on the type of hepatitis a person has, and include therapies to address the cause of liver inflammation.| Liver Disease News
Hepatitis C is a viral infection spread through contact with bodily fluids and causes a range of symptoms affecting the liver.| Liver Disease News
A genetic disease, Alagille syndrome can cause a wide range of symptoms, including liver problems, and affects about 1 in 30,000 newborns.| Liver Disease News
A range of treatment options, including medications and procedures, are available for managing Alagille syndrome symptoms.| Liver Disease News
Common symptoms of cholestasis, a condition affecting the flow of bile from the liver, include jaundice and itchy skin.| Liver Disease News
Cholestasis, or problems with liver bile flow, can have different causes and occur in pregnancy, with symptoms like jaundice and dark urine.| Liver Disease News
Category archive page for News.| Liver Disease News
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.| Liver Disease News
The American Liver Foundation's 2025 Liver Life Walk spotlights Domenic Frappolli of Dallas, who was born with biliary atresia.| Liver Disease News
Category archive page for Columns.| Liver Disease News
